Patents by Inventor Aileen Cleary

Aileen Cleary has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Truncated CRAF1 inhibits CD40 signaling
    Patent number: 6822070
    Abstract: Overexpression of a CRAF1 (CD40 receptor-associated factor 1) gene truncated by 323 to about 414 amino acids at the amino inhibits CD40-mediated cell activation, and is used to treat conditions characterized by an unwanted level of CD40-mediated intracellular signaling.
    Type: Grant
    Filed: March 10, 1997
    Date of Patent: November 23, 2004
    Inventors: David Baltimore, Genhong Cheng, Zheng-Sheng Ye, Seth Lederman, Aileen Cleary
  • TRUNCATED CRAFI INHIBITS CD40 SIGNALING
    Publication number: 20020031522
    Abstract: Overexpression of a CRAF1 (CD40 receptor-associated factor 1) gene truncated by 323 to about 414 amino acids at the amino inhibits CD40-mediated cell activation, and is used to treat conditions characterized by an unwanted level of CD40-mediated intracellular signaling.
    Type: Application
    Filed: March 10, 1997
    Publication date: March 14, 2002
    Inventors: DAVID BALTIMORE, GENHONG CHENG, ZHENG-SHENG YE, SETH LEDERMAN, AILEEN CLEARY